British Journal of Dermatology · 2019 · 21 citations · 16 references
PharmacyDermatologyMedicinal ChemistryDrug DesignDrug DiscoverySynthetic Medicinal ChemistryCombinatorial Peptide SynthesisHyperpigmentation TreatmentPeptide ChemistryPeptide Drug DiscoveryMelanin BiosynthesisMelanin FormationMelanin ProductionMelanin SynthesisPeptide Library ScreeningPeptide Medicinal ChemistrySkin HyperpigmentationTargeting Peptides
BACKGROUND: Antimelanogenic peptides are potentially useful to treat hyperpigmentation, but many peptides have limited application because of high cost and/or low activity. OBJECTIVES: To identify small and potent peptide inhibitors of cellular melanin synthesis that are useful for cosmetic and medical applications. METHODS: A positional scanning synthetic tetrapeptide combinatorial library was used for screening of potentially active peptides. Antimelanogenic activities of the peptide pools and individual peptides were evaluated in B16-F10 melanoma cells and human epidermal melanocytes treated with alpha-melanocyte-stimulating hormone (α-MSH). RESULTS: ·HCl suppressed the phosphorylation levels of cAMP-responsive element binding protein, protein levels of microphthalmia-associated transcription factor and tyrosinase, l-tyrosine hydroxylase activity of tyrosinase, and the melanin levels in stimulated cells. CONCLUSIONS: Small peptides, including glycinamide and tryptophanyl glycinamide, are potent antimelanogenic agents with potential value for the treatment of skin hyperpigmentation.
16
Ken‐ichi Yasumoto, Kouji Yokoyama, Kazuhiro Takahashi et al. · Journal of Biological Chemistry · 1997 · 391 citations · Full text